Brain trauma treatment developer BioDirection announced that it leased a facility in Albuquerque, N.M., for manufacturing a critical component of its proprietary biosensor cartridge. The new 9,000 square-foot facility in Albuquerque is slated to house manufacturing of the Tbit system’s biosensor cartridge. The Tbit system is designed to use the proprietary biosensor technology to rapidly […]
Cantel Medical taps ex-Cardinal Health vet for CEO Cantel Medical (NYSE:CMD) said today that it named former Cardinal Health (NYSE:CAH) COO George Fotiades to be its new president & CEO, replacing Jorgen Hansen effective immediately. Fotiades will retain his seat on Cantel’s board, the Little Falls, N.J.-based company said. “On behalf of the board, I am very […]
BioDirection said today that it won an FDA breakthrough device designation for its Tbit point-of-care blood test for concussion diagnosis. The Boston-based company’s Tbit system is designed to rapidly detect and accurately measure protein biomarkers that are released from the brain following a head trauma. “We are pleased to receive this FDA designation and believe it […]
BioDirection said today it raised $2 million in interim financing to support the clinical development of its Tbit point-of-care blood test for concussion diagnosis. The round was joined by Provident Healthcare Capital, MedScience Ventures and others, the Boston-based company said. The financing round brings the total raised for the company up to approximately $12 million. […]
The FDA today announced plans for a workshop to discuss the development of technologies for detecting biomarkers related to traumatic brain injuries. The aim of the workshop is to discuss both the challenges and solutions related to biomarker development methodologies, the FDA said. During the meeting, the agency will seek to establish strategies for standardizing […]
BioDirection said today it raised $4 million in a Series B convertible preferred stock financing round to support its Tbit rapid point-of-care concussion test. The Tbit blood test is designed to detect and measure protein biomarkers released from the brain following head trauma to identify concussions and traumatic brain injuries in less than 90 seconds, […]
Covidien (NYSE:COV) is set to close a $350 million buyout of Israeli lung diagnosis firm superDimension by the end of the week, according to Israeli business journal Calcalist.
Founded in Tel Aviv by Pinchas Gilboa, Minneapolis-based superDimension, which employs about 120 people worldwide, also has offices in Dusseldorf, Germany.